Faculty Bio

	On-line self-learning program
	Faculty Bio for: Troy Moore PharmD Biography Dr. Moore received his Doctor of Pharmacy Degree from the University of New Mexico in 2003 and his Masters of Pharmacy from the University of Texas at Austin in 2005. He then completed two years of psychiatric pharmacy residency in 2005 at the San Antonio State Hospital and the South Texas Veterans Health Care System (STVHCS). He obtained his Board Certification in Psychiatric Pharmacy (BCPP) from the Board of Pharmaceutical Specialties in December 2005. Current Pharmacy Practice/Role/Responsibilities Dr. Moore is an Assistant Professor in the Department of Psychiatry (Division of Schizophrenia and Related Disorders) at the University of Texas Health Science Center at San Antonio and Adjunct Assistant Professor at the University of Texas at Austin (UT) College of Pharmacy. He had the great opportunity to be a contributor on the Mental Health Treatment Study (MHTS), which was completed in the Summer of 2010. He served as a supervisor, trainer and consultant for all the study nurses, and quality assurance assessor of the medication management portion of this large, multisite study, as well as an active contributor to the latest Texas Medication Algorithm Project (TMAP) Schizophrenia Algorithm Update and was first author on the publication. Dr. Moore is also a Clinical Pharmacy Specialist in Psychiatry at the South Texas Veterans Health Care System in the Substance Abuse and the Domiciliary Residential Rehabilitation Programs. Much of his time is spent on the treatment of veterans with mental illnesses or dual diagnoses (mental illness and substance abuse). He is also heavily involved in the College of Psychiatric and Neurologic Pharmacists (CPNP) and is the 2012-14 Member-at-Large on the CPNP Board of Directors. Current Projects/Research Interests Much of the research Dr. Moore has been involved in has focused on the improvement of medication management in individuals with serious mental illness. Most of his recent research endeavors have been examining treatment outcomes and medication com Close this Window

On-line self-learning program

Biography

Dr. Moore received his Doctor of Pharmacy Degree from the University of New Mexico in 2003 and his Masters of Pharmacy from the University of Texas at Austin in 2005. He then completed two years of psychiatric pharmacy residency in 2005 at the San Antonio State Hospital and the South Texas Veterans Health Care System (STVHCS). He obtained his Board Certification in Psychiatric Pharmacy (BCPP) from the Board of Pharmaceutical Specialties in December 2005.

Current Pharmacy Practice/Role/Responsibilities

Dr. Moore is an Assistant Professor in the Department of Psychiatry (Division of Schizophrenia and Related Disorders) at the University of Texas Health Science Center at San Antonio and Adjunct Assistant Professor at the University of Texas at Austin (UT) College of Pharmacy. He had the great opportunity to be a contributor on the Mental Health Treatment Study (MHTS), which was completed in the Summer of 2010. He served as a supervisor, trainer and consultant for all the study nurses, and quality assurance assessor of the medication management portion of this large, multisite study, as well as an active contributor to the latest Texas Medication Algorithm Project (TMAP) Schizophrenia Algorithm Update and was first author on the publication. Dr. Moore is also a Clinical Pharmacy Specialist in Psychiatry at the South Texas Veterans Health Care System in the Substance Abuse and the Domiciliary Residential Rehabilitation Programs. Much of his time is spent on the treatment of veterans with mental illnesses or dual diagnoses (mental illness and substance abuse). He is also heavily involved in the College of Psychiatric and Neurologic Pharmacists (CPNP) and is the 2012-14 Member-at-Large on the CPNP Board of Directors.

Current Projects/Research Interests

Much of the research Dr. Moore has been involved in has focused on the improvement of medication management in individuals with serious mental illness. Most of his recent research endeavors have been examining treatment outcomes and medication com

Close this Window